These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30285139)

  • 1. Reduced Opioid Marketing Could Limit Prescribing Information for Physicians-Reply.
    Hadland SE; Cerdá M; Marshall BDL
    JAMA Intern Med; 2018 Oct; 178(10):1426-1427. PubMed ID: 30285139
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced Opioid Marketing Could Limit Prescribing Information for Physicians.
    Ippolito B; Veuger S
    JAMA Intern Med; 2018 Oct; 178(10):1427. PubMed ID: 30285131
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical opioid marketing and physician prescribing behavior.
    Beilfuss S; Linde S
    Health Econ; 2021 Dec; 30(12):3159-3185. PubMed ID: 34562329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
    Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
    JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes.
    Erdek MA
    AMA J Ethics; 2020 Aug; 22(1):E681-686. PubMed ID: 32880356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design.
    Hailu AD; Workneh BD; Kahissay MH
    BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription Opioid Misuse and Overuse in the U.S.
    Fleming DA
    Mo Med; 2018; 115(3):189-190. PubMed ID: 30228715
    [No Abstract]   [Full Text] [Related]  

  • 12. US governors seek to limit opioid prescribing.
    Dyer O
    BMJ; 2016 Feb; 352():i1144. PubMed ID: 26912533
    [No Abstract]   [Full Text] [Related]  

  • 13. Restricting interactions with industry to promote evidence-based prescribing.
    Ross JS
    JAMA Intern Med; 2014 Aug; 174(8):1290. PubMed ID: 24912054
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Physicians' Perception of Barriers and Facilitators for Adopting an Opioid Prescribing Guideline in Ohio: A Qualitative Interview Study.
    Penm J; MacKinnon NJ; Connelly C; Mashni R; Lyons MS; Hooker EA; Winstanley EL; Carlton-Ford S; Tolle E; Boone J; Koechlin K; Defiore-Hyrmer J
    J Emerg Med; 2019 Jan; 56(1):15-22. PubMed ID: 30342861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Reply: Prescribing opioids.
    Tobin DG; Andrews R; Becker WC
    Cleve Clin J Med; 2016 Aug; 83(8):554-5. PubMed ID: 27505869
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid analgesics--risky drugs, not risky patients.
    Dowell D; Kunins HV; Farley TA
    JAMA; 2013 Jun; 309(21):2219-20. PubMed ID: 23700072
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Ambiguous and Restrictive Regulations on Opioid-Prescribing Practice in Georgia.
    Dzotsenidze P; Lekashvili T; Chikhladze N; Jorbenadze M; Abesadze I; Kordzaia D
    J Pain Symptom Manage; 2018 Jul; 56(1):63-71. PubMed ID: 29605272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing Opioids for Chronic Pain--Reply.
    Dowell D; Haegerich TM; Chou R
    JAMA; 2016 Aug; 316(7):774-5. PubMed ID: 27533172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.